Horace Mann Educators (NYSE:HMN) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.64 by 10.94 percent. This is a 14 percent increase over earnings of $0.50 per share from the same period last year.
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.
